Our researchers

Among the researchers at the Cancer Center are three groups: basic scientists, translational researchers and clinical researchers. The basic scientists compare normal and abnormal cells, identifying and validating targets for drug intervention in vitro and in animal models. Translational researchers look for new investigational drugs and design human trials. The clinical researchers conduct Phase I, II and III trials with patients. These scientists and physician scientists work collaboratively.

      A - E                               F - J                               K - O                               P - T                               U - Z

 

 

 U - Z

Nathan Yanasak, PhD

Molecular Oncology Program, Chaperone Biology Center for Molecular Chaperone/Radiobiology and Cancer Virology

 

 

 

 

 

 

 Paul M. Weinberger, MD

 Developmental Therapeutics

 

 

 

 

 

 

Wei-Hua Wu, PhD

Molecular Oncology Program, Genomics / Epigenomic

 

 

 

 

 

 

Robert Yu, PhD, MedScD

Molecular Oncology Program, Molecular Signaling; Institute of Molecular Medicine and Genetics

 

 

 

 

 

 

Gang Zhou, PhD

Cancer Immunology and Immunotherapy, Immunology Researcher

 

 

 

 

 

 

 

Haidong Zhu, MD, PhD

Cancer Prevention and Control

 

 

 

 

 

[Back to Top]